The Fred Hutch Postbaccalaureate Scholar Program provides recent college graduates $50,000 a year and benefits as full-time ...

An employee-engagement survey conducted last fall at Fred Hutch Cancer Center was noteworthy for its favorable overall scores ...

When Terri Rau was diagnosed with breast cancer decades after being treated for Hodgkin lymphoma, she partnered with her ...

Fred Hutch Cancer Center is steadfast in advancing our DEI strategy in order to accelerate the mission of curing cancer ...

Fred Hutch's two mobile mammography vans — “mammovans” for short — are intended to remove barriers that people face accessing ...

On September 10, experts across disciplines, from infectious disease clinicians to regulators to representatives from the pharmaceutical industry, convened at the inaugural ImmunOptimize workshop in ...

We make promising new treatments available to you through studies called clinical trials led by Fred Hutch physicians. Many of these trials at Fred Hutch have led to FDA-approved treatments and have ...

We make promising new treatments available to you through studies called clinical trials led by Fred Hutch physicians. Many of these trials at Fred Hutch have led to FDA-approved treatments and have ...

We make promising new treatments available to you through studies called clinical trials led by Fred Hutch physicians. Many of these trials at Fred Hutch have led to FDA-approved treatments and have ...

Research from the Berger lab at Fred Hutch identifies the deubiquitinase USP9X as an important factor helping to increase ...

Most often we think about cancer as developing from cells that acquire cancer-driving mutations, but there’s a subset of cancers driven by another culprit: viruses. To date, “seven human viruses have ...

Researchers at Fred Hutchinson Cancer Center, led by Dr. Julie McElrath, Director of the Vaccine and Infectious Disease Division, have found a new way to train our immune system to make antibodies ...